Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03890679 · ClinicalTrials.gov registry record · NA
Genomic Medicine for Ill Neonates and Infants (The GEMINI Study)
A NA study, sponsored by Tufts Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 400
- Enrollment target
NCT03890679 is a NA study that has completed, run by Tufts Medical Center. The registered enrollment target is 400 participants.
The verdict
NCT03890679, a NA study, has completed, sponsored by Tufts Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
Study Summary
The Genomic Medicine for Ill Neonates and Infants (The GEMINI Study) is a research study aimed at comparing the clinical and economic utility of performing rapid whole genomic sequencing versus a targeted genomic sequencing panel on neonates and infants suspected of having a genetic disorder. This study is funded by the National Institutes of Health. This multicenter, prospective clinical trial will enroll 400 subjects at the Floating Hospital for Children at Tufts Medical Center (Boston, MA), Cincinnati Children's Hospital Medical Center (Cincinnati, OH), Mount Sinai Kravis Children's Hospital (New York, NY), North Carolina Children's Hospital (Chapel Hill, NC), Children's Hospital of Pittsburgh (Pittsburgh, PA), and Rady Children's Hospital (San Diego, CA).
Interventions
- DIAGNOSTIC_TEST rapid whole genomic sequencing (rWGS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2019-05-24 |
| Est. Completion | 2022-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03890679
The ClinicalTrials.gov registry entry for NCT03890679 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tufts Medical Center, which has 169 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which rapid whole genomic sequencing (rWGS) is the first listed.
NCT03890679 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03890679 about?
NCT03890679 is a clinical study titled "Genomic Medicine for Ill Neonates and Infants (The GEMINI Study)". The Genomic Medicine for Ill Neonates and Infants (The GEMINI Study) is a research study aimed at comparing the clinical and economic utility of performing rapid whole genomic sequencing versus a targeted genomic sequencing panel on neonates and infants suspected of having a genetic disorder. This s...
What is the current status of trial NCT03890679?
This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2019-05-24. Estimated completion is 2022-11-01.
What interventions are being tested in trial NCT03890679?
The interventions under investigation include: rapid whole genomic sequencing (rWGS) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03890679?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.